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P U B L I S H E D B Y E L S E V I E R I N C .LettersParticulate Air Pollution
and Carotid Artery StenosisOutdoor ﬁne particulate air pollution (mass concen-
tration of particles <2.5 mm in diameter [PM2.5])
exposure is ubiquitous and is associated with car-
diovascular mortality and ischemic heart disease
events (1). PM2.5 exposure also increases the risk for
ischemic stroke (2). The vascular and hemodynamic
effects of PM2.5 may explain some, but not all, of
this increased risk (2). However, it is unknown
whether PM2.5 is associated with prevalent clinical
atherosclerosis, such as carotid artery stenosis
(CAS), a lesion critical to the pathophysiology of
ischemic stroke (3). To achieve this objective, we
examined PM2.5 and prevalent CAS among more
than 300,000 residents of New York, New Jersey,
and Connecticut.
We selected tristate residents age 40 to 80 years
participating in Life Line Vascular Screening (LLS,
Independence, Ohio) without previous procedures for
carotid disease (N ¼ 307,444). The cohort consisted
primarily of individuals who self-paid for vascular
screening tests from 2003 to 2008 in the tristate re-
gion (4), This region was chosen because of its large,
heterogeneous population and wide variation in
PM2.5 exposure (6.7 to 14.7 mg/m3). Prior to vascular
ultrasound, participants completed demographic,
smoking, medical comorbidity, cardiovascular risk
factor, and family history questionnaires (4). CAS
was assessed with bilateral carotid artery duplex
ultrasound. Maximal peak systolic and end diastolic
velocity in the right and left internal carotid
arteries (ICA) were recorded. CAS was deﬁned as
stenosis $50% in either ICA (or both ICAs) by
duplex ultrasound (ICA peak systolic velocity $125
cm/s) (3,5). Each participant’s average PM2.5
exposures were estimated by zip code empirical
Bayesian kriging of ambient monitoring data from
the Environmental Protection Agency’s Air Quality
System. PM2.5 exposures from years 2003 to 2008
were selected for analysis due to completeness
of Life Line cohort screening data. Baseline
characteristics and CAS prevalence by PM2.5
quartiles were examined. Multivariable logisticregression models, sequentially adjusting for age,
demographics, medical history, and zip code median
household income, were used to estimate the risk of
CAS per 10 mg/m3 increase in PM2.5. Additional
multivariable logistic regression by quartiles and
medians of PM2.5 exposure on risk of CAS was
performed. Sensitivity analyses of moderate and
severe CAS were also conducted.
Compared with other quartiles of PM2.5 exposure,
participants in quartile 4 (12.9 to 14.7 mg/m3) were
younger, and were less likely to be white, have
hypertension, have hyperlipidemia, or exercise regu-
larly; however, they were more likely to have diabetes
mellitus (p<0.001 for all). Ina logistic regressionmodel
adjusting for age, sex, race/ethnicity, bodymass index,
high cholesterol, hypertension, physical activity,
family history of cardiovascular disease, household
income, and smoking behaviors, we found a nearly
2-fold increase in CAS (odds ratio [OR]: 1.90, 95% con-
ﬁdence interval [CI]: 1.35 to 2.66) for every 10-mg/m3
increase in PM2.5. The odds of CAS increased when
the highest versus lowest quartile of PM2.5 and above
and below the median PM2.5 were compared (OR:
1.24,95%CI: 1.11 to1.37;andOR:1.12,95%CI: 1.04to1.21,
respectively) (Figure 1). Results were similar by sex
and race. The association between a 10-mg/m3 increase
in PM2.5 and CAS was consistent when restricted to
patients with moderate (OR: 1.90, 95% CI: 1.31 to 2.72)
and severe (OR: 1.79, 95% CI: 1.05 to 3.07) CAS.
Our study demonstrates for the ﬁrst time that PM2.5
is independently associated with CAS, an important
risk factor for cerebrovascular disease and stroke.
These results support the relationship between
ﬁne particle air pollution and prevalent atheroscle-
rosis, and may suggest a pathway through which
PM2.5 increases cardiovascular risk. Strengths of this
study include the large sample size, validated CAS
measurements, wide age range, and availability of
lifestyle, medical, and household income data. Limi-
tations include the lack of complete temporal data
on PM2.5 exposure and clinical outcomes for CAS. Our
assessments of cardiovascular risk factors were
limited to self-report, and we lacked data on medical
therapy that could modify the relationship of PM2.5
exposure to CAS. As this is a cross-sectional study,
we cannot rule out exposure misclassiﬁcation or
the effect of copollutants on the observed PM2.5 to

















Odds Ratio for Carotid Artery Stenosis
Odds ratios adjusted for age, sex, race/ethnicity, body mass
index, dyslipidemia, hypertension, diabetes, physical activity
(yes/no), family history of cardiovascular disease, socioeconomic
status, and smoking. PM2.5 ¼ the mass concentration of
particles <2.5 mm in aerodynamic diameter; Q ¼ quartile.
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Neurotrophic Factor as
a Marker for Immediate
Assessment of the
Success of Renal
Sympathetic DenervationThe renal sympathetic denervation (RSD) is an inter-
ventional treatment option in resistant hypertension
when optimal medical treatment fails, but this pro-
cedure has proved unsuccessful in some patients
(1). Therefore, identifying patients who would
potentially beneﬁt from RSD remains a major
clinical challenge. The sympathetic stimulation of
the cardiovascular system is partly regulated by
nerve growth factors and neurotrophic factors (2).
Brain-derived neurotrophic factor (BDNF) is the
most investigated member of the neurotrophin
family and is an important modulator of the
synaptic plasticity and activity of the sympathetic
nervous system (2). Therefore, the primary aim of
the present analysis was to evaluate whether
BDNF would indicate successful denervation of the
sympathetic nerve ﬁbers and provide immediate
assessment of a sufﬁcient RSD procedure.
A total of 100 consecutive patients with resistant
hypertension who underwent RSD were included in
the study. Ofﬁce and ambulatory blood pressure
measurements (ABPMs) were obtained at baseline
and 6 months after RSD. Ofﬁce blood pressure (BP)
was measured in each arm in the morning with pa-
tients in a sitting position after resting for at least
5 min. The arm with the higher BP was used for sub-
sequent readings. Venous blood samples for deter-
mination of BDNF levels were collected at baseline
